The presentation outlines the importance of establishing an integrated approach in evidence generation to deliver a unified value proposition and discusses the challenges that an organisation must overcome when there is not such an approach in place. Finally, we lay out a set of benefits that pharmaceutical companies can realise from establishing of an IEGP process.